How should capital read San Diego in 2026: as a Tier 1 life sciences recovery market, a defense-and-cross-border industrial niche, a coastal multifamily income hold, or a place where selectivity within every asset class is the entire thesis?

Source: Cushman & Wakefield San Diego Life Sciences MarketBeat Q2 2026 answers the first lane cautiously: 26.9% vacancy was a new cycle high, YTD absorption was -477,995 SF, total availability was about 30.2%, and rent declined 3.3% year over year. Torrey Pines still outperformed at 13.3% vacancy and positive Q2 absorption, while Sorrento Mesa remained 39.9% vacant. Keep life sciences in the Tier 1 cluster / distressed-basis lane, with recovery driven by a mostly preleased build-to-suit pipeline and no expected new speculative starts.

San Diego is a multi-cluster specialty market, not a broad growth market and not a gateway play in the traditional sense. Through Q2 2026, it deserves capital attention for three specific reasons and skepticism about a fourth. Life sciences is the defining cluster — a 27.3M SF Tier 1 market mid-correction, with Torrey Pines materially outperforming Sorrento Mesa. Industrial is digesting a prolonged spec cycle; broker Q2 operating rows disagree on the magnitude and sign of absorption, while Matthews adds a tenant-favorable -215,000-SF / 9.3%-vacancy read beside active quality-selective investment sales. Coastal multifamily remains the cleanest defensive income trade given geography-constrained supply. Office is the asset class to avoid broadly and approach narrowly. Capital that cannot execute with submarket and asset-quality precision should stay out; capital that can should find real opportunities across at least three asset classes.

CBRE's official Q1 2026 industrial row forces a stricter read of that industrial inflection. CBRE reported -554,857 SF absorption, 6.7% vacancy, 9.7% availability, $1.41/SF/month asking rent, 946,266 SF under construction, 11 projects underway, and 125,076 SF delivered. That does not erase Kidder's positive-absorption Otay Mesa signal or C&W's nearly flat absorption row, but it means the correct industrial posture is source-labeled stabilization watch, not confirmed recovery. See Source: CBRE San Diego Industrial Figures Q1 2026.

Source: Colliers San Diego Region Industrial Report 2026 Q1 adds the constructive same-quarter counterpoint: +1.31M SF of absorption, 7.07% vacancy, $1.57/SF/month NNN rent, and 809,179 SF under construction. It strengthens the Otay Mesa / build-to-suit catalyst narrative, but it does not turn San Diego industrial into broad beta because Colliers also reports a 3.7% year-over-year rent decline and 0% preleasing on the remaining pipeline.

Source: JLL San Diego Industrial Market Dynamics Q1 2026 adds the JLL source-family row between the CBRE and Colliers reads: +220,374 SF of Q1/YTD absorption, 7.7% vacancy, 11.9% availability, $1.29/SF/month NNN rent, 945,579 SF under development with 0.0% preleasing, and rising concessions. The allocation read stays selective. JLL supports a defense / North County / cross-border recovery watch, but it also says Q1 leasing volume was the lowest first-quarter total in a decade and Otay Mesa vacancy reached 15.7%.

Source: Marcus & Millichap San Diego Industrial Market Report 2Q 2026 adds the later Marcus check on that exact industrial lane. It reports 1.1M SF of net absorption over the six months ending March 2026 and says sub-50,000-SF leasing matched the prior six-month span, but it also says the absorption was tied to an Amazon move-in of similar size near the U.S.-Mexico border and that nearly half of scheduled completion space was available as of April. The allocation implication is unchanged but better evidenced: San Diego industrial is an Otay Mesa / cross-border recovery-watch and small-space-demand story, not a broad metro industrial beta trade.

Source: CBRE San Diego Industrial Figures Q2 2026 updates the same lane with a full current-quarter table: 6.5% vacancy, 9.6% availability, +132,372 SF Q2 absorption but -276,000 SF YTD, no deliveries, 943,730 SF under construction, and $1.40/SF/month NNN direct asking rent. The product split matters: distribution/logistics absorbed +416K SF in Q2 while manufacturing/general and R&D/flex recorded -180K and -162K SF, and Class A vacancy was 15.0%. East County's 1.4% vacancy contrasted with South San Diego's 10.3% vacancy and 746K SF pipeline. This is modest stabilization within CBRE's universe, not a broad upgrade to San Diego industrial beta.

Source: Cushman & Wakefield San Diego Industrial MarketBeat Q2 2026 adds the same-source Q2 comparison: 7.2% vacancy, +36,520 SF Q2 absorption, +41,453 SF YTD absorption, 1.8M SF Q2 leasing, 1.42M SF under construction, 6.6M SF proposed pipeline, and $1.44/SF/month NNN rent. Central County was 5.1% vacant, South County 11.2%, manufacturing 4.4%, and W/D 9.8%. This confirms modest stabilization in C&W's universe while direct availability reached 8.8% and Q2 investment volume fell 31% year over year to $217M. Keep this row separate from CBRE's more positive Q2 absorption and from the other broker universes; the combined allocation posture remains an Otay Mesa / defense / cross-border recovery watch, not broad industrial beta.

Source: Matthews San Diego CA Industrial Market Report Q2 2026 adds a distinct Matthews / CoStar operating-and-capital row: 9.3% vacancy, -215,000 SF Q2 absorption, $21.99/SF annual asking rent, -1.4% rent growth, and 1.6M SF under construction, alongside $296M of Q2 sales, $319/SF average pricing, and a 6.4% average cap rate. The useful allocation signal is bifurcation, not reconciliation. Softer leasing and concessions coexist with transaction demand for well-located, high-quality, occupied assets; those market aggregates should never replace matched tenant, lease-duration, and asset-quality comps.

The Westfield UTC buyout source adds a fourth, narrower read: San Diego has flagship retail / amenity nodes that matter because they strengthen adjacent office, life-sciences, and residential districts. properties.id=5393 captures URW's conditional $705M buyout of the remaining 50% stake as a pending control event for a roughly 1 million SF UTC open-air center. Use it as UTC mixed-use quality and retail-platform conviction evidence, not as a broad retail allocation lane or a source for mall sales, NOI, cap rates, valuation, or tenant economics.

Source: JLL San Diego Office Market Dynamics Q1 2026 adds the JLL office source-family row to the CBRE / Colliers office stack. It reports +40,546 SF of Q1/YTD absorption, 14.2% vacancy, $3.39/SF overall direct rent, $3.86/SF Class A direct rent, 289,483 SF under development with 0.0% preleasing, and $440M of Q1 sales at $287/SF average pricing. That supports stabilization-watch and capital-market liquidity, but the source also says Q1 leasing volume was only 900,000 SF versus a 1.2M SF 2024 quarterly average and 1.7M SF 10-year average, so the allocation lane stays corridor-selective.

Source: Marcus & Millichap San Diego Office Market Report 1Q 2026 adds the Marcus teaser version of the same office lane. It supports selective stabilization because suburban vacancy was roughly 14%, Class A leasing improved in suburban submarkets, high-quality demand was strongest north of San Diego along I-5, and local construction was pulling back. It does not support broad office beta: downtown availability was roughly 33% at the beginning of 2026, described as the highest among major U.S. CBDs, and the downtown/suburban vacancy spread was nearly 2,000 bps.

Source: Cushman & Wakefield San Diego Office MarketBeat Q2 2026 adds the current C&W office row: 15.0% vacancy, +214,375 SF Q2 / -84,203 SF YTD absorption, 1.354M SF of YTD new leasing, $3.51/SF/month FSG rent, and 242,774 SF under construction. Central County's +267,365 SF quarter and the UTC / Del Mar Heights / Scripps / Kearny Mesa transaction list support the selected-corridor lane. North County's negative demand, South County's 20.0% vacancy, Downtown's 28.8% direct vacancy, and Class A's negative YTD absorption keep broad office beta outside the allocation set.

Source: Cushman & Wakefield San Diego Medical Office MarketBeat Q2 2026 adds a separate healthcare-office lane. Its reconciled detailed table reports 6.7% vacancy across 14.86M SF, -50,152 SF Q2 / -14,215 SF YTD absorption, $3.85/SF/month FSG rent, 1.9% annual rent growth, and only 143,057 SF under construction. That is materially tighter than conventional office and lab space, but it is not broad MOB permission: off-campus space carried the full Q2 absorption loss, Class B vacancy was 8.6%, and North County vacancy was 9.3%. The investable lane is tenant-credit, service-line, referral-network, lease-term, and buildout specific. The source's 6.2% narrative headline conflicts with its 6.7% detailed total; allocation uses the reconciled table value.

Source: Marcus & Millichap San Diego Multifamily Market Report 1Q 2026 adds the 2026 apartment demand-side check. It supports the coastal defensive-income thesis because San Diego vacancy held in the low-4% band over the prior three years despite 13,000 units added, and the 20- to 34-year-old cohort accounted for 22% of local population entering 2026. The caveat is local supply concentration: 1,700 units were underway in Balboa Park-adjacent neighborhoods, including Bankers Hill, so urban-core Class A lease-up still needs separate diligence.

Source: Marcus & Millichap San Diego Hospitality Market Report 1Q 2026 adds a hospitality overlay to the same specialty-market thesis. It supports hotel demand around San Diego International Airport records, downtown / airport / Carlsbad-Oceanside improvement, LEGOLAND California's LEGO Galaxy opening, expanded cruise service, and the 2028 Terminal 1 completion. It also adds a supply-digestion gate: the 1,600-room Gaylord Pacific Resort & Convention Center could continue to pressure overall occupancy in 2026.

• Among the tracked peer set, San Diego is unusual in combining a top-tier life sciences cluster, a significant defense-aerospace institutional demand floor, a cross-border industrial submarket with genuine structural trade volume, and a geography-constrained coastal multifamily market in the same metro.
• The Torrey Pines / UCSD / Scripps / Salk corridor is one of the most defensible anchor ecosystems in U.S. life sciences. FDA-credentialed facilities can have switching costs that exceed relocation economics for many occupiers. Per Life Sciences and Lab Underwriting, renewal probability on true cGMP manufacturing nodes exceeds 90%; apply that only where the asset is actually a cGMP / FDA-validated facility.
• Defense and MRO demand (NASSCO shipbuilding, Northrop Grumman, L3Harris, multiple Navy and Marine installations) creates an industrial demand floor that is completely uncorrelated with biotech venture cycles or e-commerce demand. This is structural, not cyclical.
• The national lab pipeline collapse — from 15.4M SF spec starts in 2022 to 2.4M SF in 2025 — is the most important supply-side number in the current life sciences cycle. The correction is already becoming self-limiting. San Diego remains one of the largest U.S. lab clusters by inventory, but the local construction-pipeline read still needs source specificity because CBRE's atlas records 1.6M SF under construction. For long-duration core lab investors, the entry window is widening where basis, tenant credit, and submarket tier are right.
• The source stack reports $3.3B in 2024 VC funding for San Diego life sciences companies and NIH funding above $1B to San Diego organizations in FY 2024. Treat those as source-note-supported demand-depth indicators rather than DB observations. The demand-side institutional base has not left; it contracted from a boom-era peak.
• Multifamily scarcity is geography-enforced, not policy-enforced. The Pacific Ocean, the coastal mountains, and the Mexican border create a supply wall that no zoning change can fully remove. This makes San Diego's 5.4% overall vacancy structurally more defensible than equivalent vacancy in inland Sun Belt markets with open land.

• Do not average across the life sciences market. The Torrey Pines/Sorrento Mesa spread — 10.2% versus 39.7% vacancy — is the most important single data point in the market. Investors underwriting "San Diego life sciences" as a uniform beta trade will own Sorrento Mesa exposure without knowing it.
• The Q4 2025 Savills update noted that five former Pfizer buildings could push Torrey Pines wet lab availability toward ~45%. That is a near-term supply event in the tightest submarket in the county — track the Pfizer building disposition carefully before making any new Torrey Pines lab investments.
• Do not treat the industrial Q1 2026 absorption inflection as a full market turn. Otay Mesa drove +851,435 SF of Kidder's +250,483 SF county-wide figure, but CBRE's official Q1 2026 page reports -554,857 SF of market absorption and C&W reports -5,291 SF. Otay Mesa vacancy is 12.2% with $1.08/SF/month asking rent; that is a tenant's market, not a landlord's market. The inflection is source-family-specific and fragile.
• Office vacancy methodology differences are material. C&W reports 14.6% metro-wide versus Newmark's 20.2% (broader universe including flex/R&D). Downtown vacancy is 27.9% by C&W and 35.8% by Kidder Mathews using a broader CBD definition. The headline number is less important than knowing which submarket you are actually underwriting.
• CBRE's Q1 2026 San Diego office row is a stabilization-watch input, not a recovery permission slip. It reports positive 16,231 SF absorption and vacancy down 20 bps QoQ, but availability rose to 19.5% for a third consecutive quarter and 2025 had produced a cumulative 609K SF net loss. Keep CBRE, C&W, Newmark, and Kidder definitions separate before changing the office allocation lane.
• Colliers' Q1 2026 San Diego Region row is the more constructive broker-family check: +276,048 SF absorption, 13.90% vacancy, and rising overall / Class A asking rents. Treat it as added evidence for selective stabilization in the traditional office universe, not as a Downtown recovery claim or a reason to merge broker vacancy definitions.
• JLL's Q1 2026 San Diego office row is a useful third source-family check, not a broad upgrade. It reports positive absorption, rent growth, low construction, and active sales, but leasing volume remained below the 2024 quarterly and 10-year averages and concessions were still rising. Keep JLL's 14.2% vacancy and $440M sales-volume row separate from CBRE and Colliers definitions.
• Marcus & Millichap's 1Q 2026 San Diego office teaser supports the flight-to-quality and construction-pullback thesis but should not be treated as a complete operating table. Its most useful allocation details are roughly 33% downtown availability, a nearly 2,000-bp downtown/suburban vacancy gap, roughly 14% suburban vacancy, Class A leasing improvement, and better high-quality demand north of San Diego proper along Interstate 5.
• C&W's Q2 2026 continuation strengthens selective stabilization through positive quarterly absorption, a 49% quarterly rebound in new leasing, and low active construction. It also preserves the reject rule: first-half absorption remained negative, North County lost occupancy, South County was 20.0% vacant, and Downtown direct vacancy was 28.8%.
• Multifamily Class A vacancy at 10.2% versus overall 5.4% (Q3 2025, Matthews) mirrors the life sciences story: new speculative supply is the stress vector, not broad demand erosion. Capital targeting stabilized existing product is in a different market than capital chasing newly delivered luxury towers.
• Marcus & Millichap's 1Q 2026 multifamily teaser supports the same split: broad demand is strong enough for low vacancy, but the 1,700-unit Balboa Park / Bankers Hill construction node can still create local lease-up friction. Do not use the low-4% vacancy-band language as permission to ignore project-level concessions or competing deliveries.
• Asking rent momentum across all asset classes is negative. Lab rents fell for 14 consecutive quarters. Industrial rents fell -3.9% YoY. Office rents fell -1.4% (all classes) and -1.5% (Class A). Multifamily rent growth was +0.2%. This is not a market that rewards broad income growth assumptions in underwriting.
• Matthews' Q2 industrial capital-market row is not proof that operating weakness is priced away. Its $296M of sales, $319/SF pricing, and 6.4% cap rate sit beside -215,000 SF absorption and -1.4% rent growth. Treat that as evidence of quality and income-duration selection, not a metro-average valuation shortcut.
• Small neighborhood-service mixed-use trades should not be mistaken for the institutional San Diego thesis. La Mesa Mixed-Use at 6760 University Avenue adds a 12,196 SF office / retail service-tenant comp, but the article did not disclose price, buyer, or seller. It belongs in the data-tier comp set, not as evidence that broad office capital should loosen. See Source: La Mesa Mixed-Use San Diego Sale.
• Westfield UTC is the opposite scale of retail evidence: a flagship open-air center and UTC amenity-control marker. The pending stake buyout supports select flagship retail conviction, but it still does not supply tenant sales, rent, NOI, cap-rate, or closed-sale proof. See Source: URW Westfield UTC Buyout 2026.
• Matthews' San Diego retail row improves the retail evidence layer but does not turn retail into the lead San Diego allocation thesis. The source supports tight vacancy, high rents, and prime-location landlord leverage, while also flagging store-closure backfill, slower rent growth, tariff / consumer-spending pressure, and buyer / seller pricing gaps. See Source: Matthews San Diego CA Retail Market Report Q2 2025 and San Diego Retail and Consumer Market.
• Marcus & Millichap's 1Q 2026 San Diego retail teaser sharpens the same selective retail lane. The source supports Central San Diego as the stabilizing node, but it also says the metro recorded net relinquishment in 2025 and faces another wave of store closings. Keep retail below the core San Diego life-sciences / multifamily / selective industrial lanes unless the asset has direct trade-area, tenant-sales, and backfill proof.
• C&W's Q2 2026 retail table confirms that scarcity is format-specific. The near-empty 10,885-SF pipeline limits supply risk, but negative quarterly and YTD absorption plus 10.6% regional-center vacancy block a broad retail upgrade. Power centers at 2.9% vacancy and South County at 4.4% are investable screens, not substitutes for center-level operating evidence.
• Matthews' Q2 2026 retail continuation supplies the constructive source-family counterpoint: 4.5% vacancy, +61,600 SF of quarterly absorption, only 287,000 SF under construction, $502M of Q2 sales, and a 5.8% cap rate. Keep the upgrade narrow because rent growth was -0.6%, the source lacks center-type segmentation, and its geography is not interchangeable with C&W's shopping-center inventory.

San Diego fits capital that combines deep cluster conviction with submarket precision. The strongest profiles are:

• Selective core lab investors with long duration, institutional-quality sponsors, and patience for life sciences absorption cycles. Torrey Pines and UTC are the right submarkets; Sorrento Mesa at attractive basis is a value-add story that requires clear leasing roadmaps.
• Defense-linked industrial owner-user capital that can anchor to institutional MRO, shipbuilding, or aerospace demand without depending on e-commerce or cross-border speculation for IRR.
• Core coastal multifamily income buyers who value geography-enforced supply constraint over near-term rent growth. This is a hold-and-collect market, not a lease-up market.
• Selective medical-office investors with health-system or strong physician-group credit, sticky service lines, patient-access locations, specialized improvements, and lease duration that justifies the re-tenanting risk. Low metro vacancy does not substitute for lease-level diligence.
• Opportunistic office capital underwriting specific distressed assets in Downtown at sub-$200/SF with a clear conversion or repositioning playbook. This is not a trophy-office acquisition market for most buyers at current pricing — it is a distressed resolution market at the CBD end.
• Long-duration cross-border industrial capital willing to hold Otay Mesa at current basis ($1.08/SF/month) for the structural maquiladora and nearshore manufacturing story, with underwriting that does not require immediate rent recovery.

Capital that does not fit: broad industrial beta seekers, spec lab developers without a named tenant, broadly diversified office acquirers, and any buyer treating San Diego as a single uniform market narrative.

San Diego's life sciences correction is tracking the Boston pattern. Boston-Cambridge vacancy reached 28.8% at year-end 2025; San Diego reached 28.6% in Q4 2025. Both markets experienced the same post-2021 supply-cycle reset. Both retain structural cluster depth that weaker markets (Raleigh-Durham at 32.3% vacancy, with fewer anchor-tenant stickiness mechanisms) do not replicate in the same way. See National Life Sciences Capital Allocation 2026 for the cross-cluster comparison table.

Per Life Sciences Cluster Geography, the national spec pipeline collapse to 2.4M SF in 2025 from 15.4M SF peak creates a multi-year absorption runway for both Boston and San Diego once demand stabilizes. The difference is that San Diego also has the defense/industrial and border-industrial theses working simultaneously, which gives it more allocation dimensions than a pure lab play.

San Diego is not part of the Sun Belt growth story in the same way as Phoenix, Atlanta, or Nashville. It is a coastal specialty market with a more concentrated demand base and more constrained land position. See Sun Belt Geography Hub for comparison context.

• Best capital lane: Life-sciences cluster depth, defense/cross-border industrial, and supply-constrained coastal multifamily are the best lanes.
• Strict-selection lane: Life sciences and office are investable only with tenant-credit, preleasing, and submarket tier discipline.
• Watch-list / avoid lane: Spec lab, commodity office, and inland apartment underwriting that ignores affordability/rent-ceiling pressure remain watch-list lanes.
• Canonical KB pages that changed the answer: San Diego Geography Hub, San Diego, San Diego Life Sciences — Torrey Pines and Sorrento Mesa, San Diego Industrial and Logistics, San Diego Multifamily — Coastal Moat and Urban Core, and Life Sciences Cluster Geography.
• Source-backed current measurements: 2025-2026 DB-backed San Diego life-sciences, industrial, multifamily, and office observations are source-backed when period-labeled.
• Structured observations checked: 150 San Diego observations across 22 geography rows and life-sciences, industrial, multifamily, and office property types; matched observations have public provenance from San Diego Market Intelligence 2025-2026 and the life-sciences cluster geography source trail.

• Analyses Hub
• San Diego
• National Life Sciences Capital Allocation 2026
• Life Sciences Cluster Geography
• Life Sciences and Lab Underwriting
• San Diego Medical Office Market
• Medical Office and Healthcare Real Estate Underwriting
• Boston CRE Capital Allocation 2026
• Sun Belt Geography Hub
• CRE Investment Strategy
• Office Bifurcation

• San Diego Market Intelligence 2025-2026 — Cushman & Wakefield Q3 2025 life sciences (metro vacancy 26.5%, submarket breakdown); Savills Q4 2025 life sciences (28.6% overall, Class A rent $5.86/SF/month); CBRE Global Life Sciences Atlas (inventory 27.3M SF, under construction 1.6M SF); Newmark Q3 2025 life sciences (asking rent $5.37/SF/month NNN); Cushman & Wakefield Q4 2025 industrial (vacancy 7.2%, asking rent $1.47/SF/month NNN, net absorption +592,753 SF); Kidder Mathews Q1 2026 industrial (vacancy 9.6%, Otay Mesa absorption +851,435 SF); Newmark Q4 2025 industrial (rent growth -3.9% YoY); Matthews Real Estate Q3 2025 multifamily (vacancy 5.4%, rent $2,500/unit, 8,700 units under construction, cap rate 4.7%); Cushman & Wakefield Q4 2025 office (vacancy 14.6%, Class A rent $3.87/SF/month FSG, annual leasing 3.1M SF); Kidder Mathews Q4 2025 office (Downtown 35.8%, Torrey Pines 3.5%, Del Mar Heights $4.68/SF/month, 10-submarket breakdown).
• Source: La Mesa Mixed-Use San Diego Sale
• Source: URW Westfield UTC Buyout 2026
• Source: CBRE San Diego Industrial Figures Q1 2026
• Source: Colliers San Diego Region Industrial Report 2026 Q1
• Source: JLL San Diego Industrial Market Dynamics Q1 2026
• Source: Marcus & Millichap San Diego Industrial Market Report 2Q 2026
• Source: Cushman & Wakefield San Diego Industrial MarketBeat Q2 2026
• Source: Matthews San Diego CA Industrial Market Report Q2 2026
• Source: CBRE San Diego Office Figures Q1 2026
• Source: Colliers San Diego Region Office Report 2026 Q1
• Source: JLL San Diego Office Market Dynamics Q1 2026
• Source: Cushman & Wakefield San Diego Office MarketBeat Q2 2026
• Source: Cushman & Wakefield San Diego Life Sciences MarketBeat Q2 2026
• Source: Cushman & Wakefield San Diego Medical Office MarketBeat Q2 2026
• Source: Matthews San Diego CA Retail Market Report Q2 2025
• Source: Marcus & Millichap San Diego Multifamily Market Report 1Q 2026
• Source: Cushman & Wakefield San Diego Retail MarketBeat Q2 2026